Eyecelerator 2020

Virtual Conference | Friday, Nov. 6
8 a.m. - 4:30 p.m. PT

Attend the only innovation meeting that matters — now 100% online


8:00 – 8:05 a.m.

Eyecelerator Overview

David W. Parke II, MD, Steve Speares, Gil Kliman, MD, Vance Thompson, MD, Mark Blumenkranz MD

8:05 – 9:05 a.m.

The 3C's: Impact of COVID, Capital Markets and Consolidation

Understand new marketplace forces producing opportunities and challenges. 

Moderator: Jim Mazzo
Panel 1:
Eric D. Donnenfeld, MD; Mark S. Humayun, MD, PhD; Jeffrey J. Kimbell, (jeffrey J. Kimbell & Associates, Inc.); Jim Momtazee (Patient Square Capital)
Panel 2:
Larry Biegelsen (Wells Fargo); Mike Giaquinto (SVBLeerink); Gil Kliman, MD, (InterWest Partners); Elizabeth Yeu, MD

9:05 – 10:05 a.m.

Innovations for Practice Recovery and Growth

Rapidly accelerating advances in diagnostics, therapeutics, telehealth and patient flow.

Vance Thompson, MD; Ranya Habash, MD; Eduardo C. Alfonso, MD 

10:05 – 10:28 a.m.

Mad Eye Money
Strap in for a lightning round of market analysis and ideas for financing innovation.  

Moderator: Gil Kliman, MD

Panelists: Jon Norris (Silicon Valley Bank); Brian Scullion (William Blair); Michael Lachman (EyeQ Research) 

10:28 – 10:58 a.m.

Inside the Global Game, Pt. I
Uncover key insights for advancing partnerships with industry giants.

Moderator: David W. Parke II, MD

Strategic discussion with Alcon

1. Alan Landers, OD, MS, Head, Search & Evaluation BD&L Vision Care

2. Shannon Spock, Surgical Search and Evaluation Head, Business Development and Licensing

3. Costin Curatu, Head, Search and Evaluation, Surgical BD&L

Strategic discussion with Johnson & Johnson

1. Warren Foust, Worldwide President, Surgical Vision

2. Raj Rajpal, MD, CMO, Global Head of Clinical and Medical Affairs

3. Xiao-YuSong, Global Head of Research & Development

10:58 a.m.– 12:33 p.m.

Company Showcase I: Anterior Segment/Glaucoma

Moderators: Lama A. Al Aswad, MD and Ranya Habash, MD

➢ Presbyopia/Myopia

1. LensGen

2. Visus Therapeutics

3. Yolia Health

4. SightGlass Vision, Inc.


➢ Cornea/Dry Eye

1. Aperta Biosciences

2. TearClear

3. SilkTech Biopharmaceuticals

4. Trefoil Therapeutics


➢ Drug Delivery

1. Emmecell

2. EyeYon Medical

3. AnkyrBio, LLC

4. Kedalion Therapeutics


➢ Devices and Sensors

1. Centricity Vision, Inc.

2. PreVista

3. Vision Ophthalmic

4. Implandata Ophthalmic Products GmbH

5. Injectsense, Inc.

12:33 – 1:00 p.m.

Company Showcase II: Retina Secreted Factors, Genes,  Devices

Moderators: Mark Blumenkranz, MD and Allen Ho, MD

1. Neurotech Pharmaceuticals, Inc.

2. Aviceda Ophthalmics

3. Gensight Biologics

4. Notal Vision,Inc.

5. Pixium Vision

1:00  – 1:20 p.m.

Opportunities & Challenges for Medium-Sized Companies 

Moderators: Allen Ho, MD and Sean Ianchulev, MD


Iveric Bio – Pravin Dugel, MD

RegenxBIO – Ram Palanki

1:20  – 1:47 p.m.

Company Showcase III: Advancing Trials in the Public Eye

Moderators: Mark Blumenkranz, MD and Allen Ho, MD 

1. AldeyraTherapeutics, Inc.

2. Kubota Vision

3. Ocular Therapeutix

4. Lineage Cell Therapeutics, Inc.

5. Verana Health

1:47  – 2:07 p.m.

Opportunities and Challenges for Large Companies

Moderator: Mark Blumenkranz, MD


1. Alcon – Lauren Attias

2. B+L – Chuck Hess  

3. Raymond James – Andrew Gitkin

2:07 – 2:37 p.m.

Inside the Global Game, Pt. II
Uncover key insights for advancing partnerships with industry giants.

Moderator: David W. Parke II, MD


Strategic discussion with Allergan, an AbbVie Company
1. Jag Dosanjh, Senior Vice President, Medical Therapeutics
2. Michael R. Robinson, MD, Vice President, Global Therapeutic Area Head Ophthalmology
3. Doug Faunce, PhD, Executive Director, Search and Evaluation-Eyecare Abbvie Corporate Strategy

Strategic discussion with Zeiss

1. Euan Thomson, PhD

2. Steve Schallhorn, MD

3. Andy Chang

2:37  – 3:37 p.m.

Rise of The Machines
Robotics and brain-machine interfaces are still in their infancy but they have the potential to improve outcomes for ophthalmic patients by enabling digitally-driven therapies.

Moderators: Ranya Habash, MD (BMI) and Gil Kliman, MD (Robotics)


Keynote – Surgical Robotics: Fred Moll, MD, Founder, Intuitive Surgical and Auris Health


Panelists: Fred Moll, MD, Dimitri Azar, MD, (Verily Life Sciences); Linda Lam MD, Associate Professor of Ophthalmology (USC Keck School of Medicine); Reza Zadno, CEO (Procept Biorobotics)

3:37 – 4:22 p.m.

Cultivating Diversity in Innovation

First-of-its-kind session explores the importance and measurable value of building a diverse community to advance new technology and treatments. 

Moderators: Lama A. Al-Aswad, MD, MPH and Deepinder K. Dhaliwal, MD, L.Ac


Keynote: Karin Schetelig (The Boston Consulting Group)

Panelists: Caren Mason (STAAR Surgical); Jag Dosanjh (Allergan, an AbbVie Company); Ramogal Rao (LensGen, Inc.); Todd Pinkney (Centricity Vision)

4:22  – 4:30 p.m.

Best of Show and Closing Remarks

Eyecelerator Company Pick and and People's Choice Company Pick

Presented by Co-chairs Gil Kliman, MD, Mark Blumenkranz, MD, Vance Thompson, MD

Eyecelerator is a partnership between the American Academy of Ophthalmology and ASCRS.

© 2020  Eyecelerator™

  • Twitter
  • LinkedIn